BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Vitamin E
,
rs2230926
,
CXCL2
,
G-protein-coupled receptor binding
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tcr beta genes
Summary
General Info
Curated Studies
Most Correlated Studies
CD4+ T-cells with STIM1 conditional knockout and activated in presence or absence of TGF-B
Natural killer (NK) cells of Type 1 diabetes mice after T regulatory (Treg) cell depletion
Th1 or Th2 in the presence or absence of TGFbeta
Comparison of stable human Treg and Th clones by transcriptional profiling
Regulatory and conventional T cells from TRIM28-knockout mice stimulated with anti-CD3 and anti-CD28
Explore Curated Studies Results
Literature
Most Relevant Literature
A Decentralized Kidney Transplant Biopsy Classifier for Transplant Rejection Developed Using Genes o…
Profiling the peripheral blood T cell receptor repertoires of gastric cancer patients.
Selection influences naive CD8+ TCR-β repertoire sharing.
Naïve Regulatory T Cell Subset Is Altered in X-Linked Agammaglobulinemia.
T Cell Receptor Repertoires Acquired via Routine Pap Testing May Help Refine Cervical Cancer and Pre…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR G…
MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leuk…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ